Recombinant C1 inhibitor in the prevention of severe COVID-19: a randomized, open-label, multi-center phase IIa trial

BackgroundConestat alfa (ConA), a recombinant human C1 inhibitor, may prevent thromboinflammation.MethodsWe conducted a randomized, open-label, multi-national clinical trial in which hospitalized adults at risk for progression to severe COVID-19 were assigned in a 2:1 ratio to receive either 3 days of ConA plus standard of care (SOC) or SOC alone.P

read more

Animal Welfare during Transport and Slaughter of Cattle: A Systematic Review of Studies in the European Legal Framework

Literature related to European transport and slaughter processes were included in this systematic review.The publication period is limited to the past twelve years since the European Animal Welfare Transport Regulation was enacted in 2009.Three different databases were used.The final screening resulted in the inclusion of 19 articles in this review

read more